4//SEC Filing
FERNANDEZ FERNANDO L 4
Accession 0001437749-18-017506
CIK 0000925741other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 9:16 PM ET
Size
14.6 KB
Accession
0001437749-18-017506
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA
FERNANDEZ FERNANDO L
Director
Transactions
- Award
Restricted Stock Units
2018-07-26+32,353→ 32,353 totalExercise: $0.00→ Common Stock (32,353 underlying) - Exercise/Conversion
Restricted Stock Units
2018-01-13−5,111→ 10,222 totalExercise: $0.00→ Common Stock (10,222 underlying) - Exercise/Conversion
Restricted Stock Units
2018-06-15−9,166→ 0 totalExercise: $0.00→ Common Stock (0 underlying) - Exercise/Conversion
Common Stock
2018-01-13+5,111→ 5,111 total - Exercise/Conversion
Common Stock
2018-06-15+9,166→ 14,277 total
Footnotes (10)
- [F1]Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.
- [F10]The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date. Vested shares will be delivered to the Reporting Person on July 26, 2019.
- [F2]Represents the conversion upon vesting of RSUs into common stock. On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the SEC on August 25, 2017.
- [F3]Each RSU is the economic equivalent of one share of BioCardia, Inc. common stock. The closing price of BCDA on January 12, 2018 was $2.95 per share.
- [F4]Each RSU is the economic equivalent of one share of BioCardia, Inc. common stock. The closing price of BCDA on June 15, 2018 was $1.40 per share.
- [F5]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F6]The converted RSU corresponds to a 1:1 common stock issuance.
- [F7]The converted RSU corresponds to a 1:1 common stock issuance.
- [F8]On January 13, 2017, the reporting person was granted 184,000 RSUs (15,333 after the 12-to-1 reverse split effective November 2, 2017), of which 5,111 vested on January 13, 2018. The common stock into which such vested RSUs converted on January 13, 2018 is reported on Table I of this Form 4. The remaining RSUs will continue to vest on the second and third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date.
- [F9]On June 15, 2017, the reporting person was granted 110,000 RSUs (9,166 after the 12-to-1 reverse split effective November 2, 2017), which vested on June 15, 2018. The common stock into which such vested RSUs converted on June 15, 2018 is reported on Table I of this Form 4.
Documents
Issuer
BioCardia, Inc.
CIK 0000925741
Entity typeother
Related Parties
1- filerCIK 0001214346
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 9:16 PM ET
- Size
- 14.6 KB